What is it used for?
SCEMBLIX is indicated for the treatment of adult patients with: Newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) in chronic phase (CP).This indication is approved under accelerated approval based on major molecular response rate . Continued approval for this indication may be contingent upon verification of clinical benefit in a confirmatory trial(s). Previously treated Ph+ CML in CP. Ph+ CML in CP with the T315I mutation.SCEMBLIX is indicated for the treatment of adult patients with: Newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) in chronic phase (CP).This indication is approved under accelerated approval based on major molecular response rate . Continued approval for this indication may be contingent upon verification of clinical benefit in a confirmatory trial(s). Previously treated Ph+ CML in CP. Ph+ CML in CP with the T315I mutation.
Read the primary sourceThis source does not establish current stock, import permission or personal eligibility in China. The treating clinician and provider must confirm these separately.
Product details
- Active ingredient
- asciminibasciminib
- Form and strength
- TABLET, FILM COATED · 20 mg; TABLET, FILM COATED · 40 mg; TABLET, FILM COATED · 100 mgTABLET, FILM COATED · 20 mg; TABLET, FILM COATED · 40 mg; TABLET, FILM COATED · 100 mg
- Manufacturer / applicant
- NOVARTIS PHARMACEUTICALS CORPORATIONNOVARTIS PHARMACEUTICALS CORPORATION
20 mg asciminib film-coated tablets: pale yellow, unscored, round, biconvex, with beveled edges, film-coated tablet debossed with “20” on one side and the “Novartis” logo on the other side. 40 mg asciminib film-coated tablets: violet white, unscored, round, …20 mg asciminib film-coated tablets: pale yellow, unscored, round, biconvex, with beveled edges, film-coated tablet debossed with “20” on one side and the “Novartis” logo on the other side. 40 mg asciminib film-coated tablets: violet white, unscored, round, …
Safety and clinical review
- MyelosuppressionMyelosuppression
- Pancreatic ToxicityPancreatic Toxicity
- HypertensionHypertension
- HypersensitivityHypersensitivity
- Cardiovascular ToxicityCardiovascular Toxicity
- Embryo-Fetal ToxicityEmbryo-Fetal Toxicity
Ask your clinician to review the complete label, medical history, other medicines, allergies, pregnancy or breastfeeding and any required monitoring. Do not start, stop or change treatment from this page.
Read the primary sourcePrepare your enquiry
Include the brand or generic name, strength, dosage form, requested quantity and country where care is needed. You can attach a prescription when you continue.
Questions patients ask
What is SCEMBLIX used for?
SCEMBLIX is indicated for the treatment of adult patients with: Newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) in chronic phase (CP).This indication is approved under accelerated approval based on major molecular response rate . Continued approval for this indication may be contingent upon verification of clinical benefit in a confirmatory trial(s). Previously treated Ph+ CML in CP. Ph+ CML in CP with the T315I mutation.SCEMBLIX is indicated for the treatment of adult patients with: Newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) in chronic phase (CP).This indication is approved under accelerated approval based on major molecular response rate . Continued approval for this indication may be contingent upon verification of clinical benefit in a confirmatory trial(s). Previously treated Ph+ CML in CP. Ph+ CML in CP with the T315I mutation.
This source does not establish current stock, import permission or personal eligibility in China. The treating clinician and provider must confirm these separately.
Which formulation of SCEMBLIX should I ask about?
TABLET, FILM COATED · 20 mg; TABLET, FILM COATED · 40 mg; TABLET, FILM COATED · 100 mgTABLET, FILM COATED · 20 mg; TABLET, FILM COATED · 40 mg; TABLET, FILM COATED · 100 mg
Read the primary sourceWhat determines the price of SCEMBLIX?
A current quote depends on the exact presentation, quantity, provider and access arrangements. A catalogue entry is not a stock or delivery promise. Medical charges are paid to the provider, separately from coordination fees.
What should I check before using SCEMBLIX?
Ask your clinician to review the complete label, medical history, other medicines, allergies, pregnancy or breastfeeding and any required monitoring. Do not start, stop or change treatment from this page.
Sources and review scope
FDA prescribing informationThis source does not establish current stock, import permission or personal eligibility in China. The treating clinician and provider must confirm these separately.